ARQT

Arcutis Biotherapeutics, Inc.

• Simply Wall St·4d ago

  Is Strong Q1 Growth and Reaffirmed Guidance Altering The Investment Case For Arcutis Biotherapeutics (ARQT)?

• Seeking Alpha·05/15 11:54

  Arcutis Biotherapeutics: The Dermatology Platform Is Starting To Compound

• TipRanks·05/11 12:40

  Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Centessa Pharmaceuticals (CNTA) and Radnet (RDNT)

• Simply Wall St·05/11 03:20

  A Look At Arcutis Biotherapeutics (ARQT) Valuation After Q1 2026 Results And ZORYVE Label Expansion Efforts

• TipRanks·05/11 00:23

  Arcutis Earnings Call Signals Momentum Amid Headwinds

• Simply Wall St·05/09 11:48

  Arcutis Biotherapeutics (ARQT) Is Down 11.0% After Reaffirming 2026 Guidance And Advancing ZORYVE sNDA

• PUBT·05/08 20:00

  Arcutis grants 269,000 RSUs, 70,000 stock options to new hires under inducement plan

• Reuters·05/08 20:00

  ARCUTIS BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• Simply Wall St·05/08 05:36

  Arcutis Biotherapeutics ARQT Tighter Trailing Losses Test Bullish Profitability Narrative

• Simply Wall St·05/08 05:00

  Arcutis Biotherapeutics (ARQT) Quarterly Loss After Q4 Profit Tests Bullish Profitability Narrative

• TipRanks·05/07 19:23

  Arcutis Biotherapeutics price target lowered to $34 from $35 at Morgan Stanley

• TipRanks·05/07 16:55

  Arcutis Biotherapeutics: Buy Rating Reaffirmed as Zoryve Momentum Supports Growth Outlook; $35 Price Target Maintained

• The Motley Fool·05/07 13:17

  Arcutis (ARQT) Q1 2026 Earnings Transcript

• TipRanks·05/07 11:11

  Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT) and BillionToOne, Inc. Class A (BLLN)

• Dow Jones·05/07 10:58

  Arcutis Biotherapeutics Price Target Maintained With a $36.00/Share by Needham